Rankings
▼
Calendar
PASG Q3 2019 Earnings — Passage Bio, Inc. Revenue & Financial Results | Market Cap Arena
PASG
Passage Bio, Inc.
$28M
Q3 2019 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$12M
Net Income
-$11M
EPS (Diluted)
$-9.60
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$11M
Free Cash Flow
-$12M
Stock-Based Comp.
$95,000
Balance Sheet
Total Assets
$189M
Total Liabilities
$2M
Stockholders' Equity
$187M
Cash & Equivalents
$177M
← FY 2019
All Quarters
Q4 2019 →
